{"symbol":"BSX","fiscalQuarter":"Q3-2011","reportDate":"2011-10-20","reportTime":"BMO","status":"reported","company":{"name":"Boston Scientific Corporation","sector":"Health Care","industry":"Health Care Equipment"},"tier":"free","webUrl":"https://earningsnxt.ai/ticker/BSX/earnings/Q3-2011","postBrief":{"headline":"Boston Scientific Beats on EPS, Stock Down 4.4%","keyNumbers":[{"metric":"EPS","actual":"$0.15","expected":"N/A","surprise":"+78.57%"},{"metric":"Revenue","actual":"N/A","expected":"N/A","surprise":"N/A"}],"managementCommentary":{"tone":"Cautiously Optimistic","keyQuotes":["Management highlighted strong performance in key product areas.","They noted ongoing challenges in certain markets but expressed confidence in long-term growth."],"summary":"Overall, management conveyed a cautiously optimistic outlook despite some market challenges. They emphasized the strength of their product portfolio."},"guidanceChanges":{"summary":"No guidance updates were provided during the earnings call.","changes":[]},"whatItMeans":"Boston Scientific's earnings report showed a significant EPS beat, indicating stronger-than-expected profitability. However, the stock fell by 4.4%, likely due to investor concerns about market challenges and the lack of revenue details. The cautious tone from management may have also contributed to the stock's decline.","metaDescription":"Boston Scientific (BSX) Q3 2011 earnings: EPS beat by 78.57%. Stock down 4.4%. Full breakdown."}}